The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 10,062 | 211,823 | SH | SOLE | 211,823 | 0 | 0 | ||
Alector, Inc. | COM | 014442107 | 10,679 | 1,203,462 | SH | SOLE | 1,203,462 | 0 | 0 | ||
Arbutus Biopharma Corporation | COM | 03879J100 | 2,880 | 804,446 | SH | SOLE | 804,446 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 28,886 | 245,424 | SH | SOLE | 245,424 | 0 | 0 | ||
Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 26,690 | 518,560 | SH | SOLE | 518,560 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 34,943 | 2,631,258 | SH | SOLE | 2,631,258 | 0 | 0 | ||
Cytokinetics Incorporated | COM NEW | 23282W605 | 13,940 | 1,723,170 | SH | SOLE | 1,723,170 | 0 | 0 | ||
Immunomedics, Inc. | COM | 452907108 | 22,321 | 1,161,965 | SH | SOLE | 1,161,965 | 0 | 0 | ||
Insmed Incorporated | COM | 457669307 | 44,590 | 1,533,883 | SH | SOLE | 1,533,883 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | Class A Common | G5269C101 | 1,154 | 63,922 | SH | SOLE | 63,922 | 0 | 0 | ||
Myokardia, Inc. | COM | 62857M105 | 20,016 | 384,993 | SH | SOLE | 384,993 | 0 | 0 | ||
OptiNose, Inc. | COM | 68404V100 | 25,002 | 2,427,403 | SH | SOLE | 2,427,403 | 0 | 0 | ||
Replimune Group, Inc. | COM | 76029N106 | 18,715 | 1,229,656 | SH | SOLE | 1,229,656 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 11,102 | 405,026 | SH | SOLE | 405,026 | 0 | 0 | ||
SI-BONE, Inc. | COM | 825704109 | 3,874 | 205,621 | SH | SOLE | 205,621 | 0 | 0 | ||
Voyager Therapeutics, Inc. | COM | 92915B106 | 3,403 | 177,804 | SH | SOLE | 177,804 | 0 | 0 |